Oragenics, Inc. (NASDAQ:OGEN) dropped 2% on Wednesday . The stock traded as low as $0.49 and last traded at $0.50, approximately 17,901 shares changed hands during trading. A decline of 98% from the average daily volume of 1,091,924 shares. The stock had previously closed at $0.51.
The company has a 50-day moving average of $0.46 and a two-hundred day moving average of $0.47.
About Oragenics (NASDAQ:OGEN)
Oragenics, Inc develops novel antibiotics against infectious diseases and treatments for oral mucositis. It is developing OG716, an antibiotic product candidate, which is in nonclinical testing for healthcare-associated infections, as well as other homolog antibiotic product candidates. The company is also developing AG013, which is in Phase II clinical trial for the treatment of oral mucositis in cancer patients.
See Also: Gross Domestic Product (GDP)
Receive News & Ratings for Oragenics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oragenics and related companies with MarketBeat.com's FREE daily email newsletter.